Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein

Journal of Experimental Medicine

Volumn 180, Issue 3, 1994, Pages 1115-1127

  Couillin, Isabelle ^a,b   Culmann Penciolelli, Béatrice ^a,b   Gomard, Elisabeth ^a,b   Choppin, Jeannine ^a,b   Levy, Jean Paul ^a,b   Guillet, Jean Gérard ^a,b   Saragosti, Sentob ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS MUTATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; EPITOPES; GENE PRODUCTS, NEF; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0028123067     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.3.1129     Document Type: Article

References (19)

1. Lamhamedi-Cherradi, S., B. Culmann-Penciolelli, G. Guy, M.-P. Kiény, J. Dreyfus, A.-G. Saimot, D. Sereni, D. Sicard, J.-P. Lévy, and E. Gomard. 1992. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS. 6:1249.
2. Culmann, B., E. Gomard, M.-M. Kiény, B. Guy, J. Dreyfus, A.-G. Saimot, D. Sereni, and J.-P. Lévy. 1989. An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur. J. Immunol. 19:2383.
3. + T-cells in the central region of the HIV-1 nef protein. J. Immunol. 146:1560.
4. Hadida, F., A. Parrot, M.-P. Kiény, B. Sadat-Sowti, C. Mayaud, P. Debré, and B. Autran. 1992. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilutions analysis. J. Clin. Invest. 89:53.
5. Walker, B.D., C. Flexner, K. Birch-Limberger, L. Fisher, T. Paradis, A. Aldovini, R. Young, B. Moss, and R.T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl Acad. Set. USA. 86:9514.
6. Philips, R.E., S. Rowland-Jones, D.F. Nixon, F.M. Gotch, J.P. Edwards, A.O. Ogunlesi, J.G. Elvin, J.A. Ropthbard, C.R.M. Bangham, C.R. Rizza, and A.J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (Lond.). 354:453.
7. Meyermans, A., G. Dadaglio, J.-P. Vartanian, P. LangladeDemoyen, B. Asjö, J. Plata, and S. Wain-Hobson. 1991. In vivo persistence of a HIV-l-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21:2637.
8. +A24-restricted cytotoxic T lymphocytes. J. Virol. 66:3151.
9. Connan, F., J. Hlavac, J. Hoebeke, J.-G. Guillet, and J. Choppin. 1994. A simple assay for detection of peptides promoting the assembly of class I molecules. Eur. J. Immunol. 24:277.
10. Zhang, Q.J., R. Gavioli, G. Klein, and M.G. Masucci. 1993. An HL A-All-specific motif in nonamer peptides derived from viral and cellular proteins. Proc. Natl. Acad. Sei. USA. 90:2217.
11. Foung, S.K.H., B. Taidi, D. Ness, and F.C. Grumet. 1986. A monoclonal antibody against HLA-A11 and A24. Hum. Immunol. 15:316.
12. Teillaud, J.L., D. Crevat, P. Chardon, J. Kalil, C. Goujet-Zalc, G. Mahouy, M. Vaiman, M. Fellous, and D. Pious. 1982. Mono-clonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta2-microglobulin. 1m-munogenetics. 15:377.
13. Bodmer, J.G., E.D. Albert, W.F. Bodmer, B. Dupont, H.A. Erlich, B. Mach, S.G.E. Marsh, W.R. Major, P. Purham, T. Sasasuki, et al. 1992. Nomenclature for factors of the HLA system, 1991. Immunogenetics. 36:135.
14. DiBrino, M., K.C. Parker, J. Shiloach, M. Knierman, J. Lukszo, R.V. Turner, W.E. Biddison, and J.E. Coligan. 1993. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Nall. Acad. Sei. USA. 90:1508.
15. + population. Science (Wash. DC). 260:98.
16. Eisenlohr, L.C., J.W. Yewdell, and J.R. Bennink. 1992. Flanking sequences influence the presentation of an endogenous synthesized to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
17. Martinon, F., E. Gomard, C. Flannoun, and J.-P. Levy. 1990. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur. J. Immunol. 20:2171.
18. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class-I-restricted cytotoxic T cells. J. Exp. Med. 177:1541.
19. Sloan-Lancaster, J., B.D. Evavold, and P.M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligands on live antigen-presenting cells. Nature (Lond.). 363:156.